Oragenics, Inc. (OGEN) Shareholders’ equity 2012–2024
Oragenics, Inc. (OGEN) shareholders’ equity at each fiscal year-end, per SEC filings.
$3.2MFY2024 · since FY2012: -$8.2M → $3.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $3.2M | -75.6% |
| FY2023 | $13.0M | -50.9% |
| FY2022 | $26.5M | — |
| FY2018 | $6.3M | +113.0% |
| FY2017 | $3.0M | -37.3% |
| FY2016 | $4.7M | -54.2% |
| FY2015 | $10.3M | -34.7% |
| FY2014 | $15.8M | +71.6% |
| FY2013 | $9.2M | +212.9% |
| FY2012 | -$8.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice